Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bixiang Zhang

Showing results (81-90 of 226) with videos related to

Pageof 23
Sort By:
Free Radical Biology & Medicine|November 22, 2021
FOXM1-mediated activation of phospholipase D1 promotes lipid droplet accumulation and reduces ROS to support paclitaxel resistance in metastatic cancer cellsXin Zhang, Chao Huang, Yue Yuan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 28, 2021
The crosstalk network of XIST/miR-424-5p/OGT mediates RAF1 glycosylation and participates in the progression of liver cancerDeng Ning, Jin Chen, Pengcheng Du, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 20, 2022
Hepatectomy for ruptured hepatocellular carcinoma classified as Barcelona Clinic Liver Cancer stage 0/A: The optimal treatmentFeng Xia, Zhiyuan Huang, Qiao Zhang, et al.
Frontiers in Oncology|February 1, 2021
miR-144-5p and miR-451a Inhibit the Growth of Cholangiocarcinoma Cells Through Decreasing the Expression of ST8SIA4Wan Fu, Guangcai Yu, Junnan Liang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 26, 2025
m<sup>6</sup>A-Mediated TMCO3 Promotes Hepatocellular Carcinoma Progression by Facilitating the Membrane Translocation and Activation of AKTXinxin Li, Mengzhen Han, He Zhu, et al.
International Journal of Surgery (London, England)|January 18, 2015
Perioperative antiviral therapy improves safety in patients with hepatitis B related HCC following hepatectomyBinhao Zhang, Dafeng Xu, Rui Wang, et al.
Cell Death & Disease|October 23, 2021
Circular RNA circUBE2J2 acts as the sponge of microRNA-370-5P to suppress hepatocellular carcinoma progressionLu Zhang, Yachong Liu, Haisu Tao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 16, 2024
Nano-encapsulation of drugs to target hepatic stellate cells: Toward precision treatments of liver fibrosisYue Yuan, Jiaxuan Li, Min Chen, et al.
Frontiers in Immunology|October 23, 2023
Case Report: Durable complete response of metastatic hepatocellular carcinoma with asymptomatic hyperamylasemia to combined immunotherapy of anti-cytotoxic T lymphocyte-associated antigen 4 plus anti-programmed cell death-1 antibodiesHan Gao, Rui-Zhi Chang, Xiao-Ping Chen, et al.
Gastroenterology|November 14, 2009
Antimetastatic role of Smad4 signaling in colorectal cancerBixiang Zhang, Sunil K Halder, Nilesh D Kashikar, et al.
Pageof 23

Showing results (81-90 of 226) with videos related to

Sort By:
Pageof 23
Free Radical Biology & Medicine|November 22, 2021
FOXM1-mediated activation of phospholipase D1 promotes lipid droplet accumulation and reduces ROS to support paclitaxel resistance in metastatic cancer cellsXin Zhang, Chao Huang, Yue Yuan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 28, 2021
The crosstalk network of XIST/miR-424-5p/OGT mediates RAF1 glycosylation and participates in the progression of liver cancerDeng Ning, Jin Chen, Pengcheng Du, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 20, 2022
Hepatectomy for ruptured hepatocellular carcinoma classified as Barcelona Clinic Liver Cancer stage 0/A: The optimal treatmentFeng Xia, Zhiyuan Huang, Qiao Zhang, et al.
Frontiers in Oncology|February 1, 2021
miR-144-5p and miR-451a Inhibit the Growth of Cholangiocarcinoma Cells Through Decreasing the Expression of ST8SIA4Wan Fu, Guangcai Yu, Junnan Liang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 26, 2025
m<sup>6</sup>A-Mediated TMCO3 Promotes Hepatocellular Carcinoma Progression by Facilitating the Membrane Translocation and Activation of AKTXinxin Li, Mengzhen Han, He Zhu, et al.
International Journal of Surgery (London, England)|January 18, 2015
Perioperative antiviral therapy improves safety in patients with hepatitis B related HCC following hepatectomyBinhao Zhang, Dafeng Xu, Rui Wang, et al.
Cell Death & Disease|October 23, 2021
Circular RNA circUBE2J2 acts as the sponge of microRNA-370-5P to suppress hepatocellular carcinoma progressionLu Zhang, Yachong Liu, Haisu Tao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 16, 2024
Nano-encapsulation of drugs to target hepatic stellate cells: Toward precision treatments of liver fibrosisYue Yuan, Jiaxuan Li, Min Chen, et al.
Frontiers in Immunology|October 23, 2023
Case Report: Durable complete response of metastatic hepatocellular carcinoma with asymptomatic hyperamylasemia to combined immunotherapy of anti-cytotoxic T lymphocyte-associated antigen 4 plus anti-programmed cell death-1 antibodiesHan Gao, Rui-Zhi Chang, Xiao-Ping Chen, et al.
Gastroenterology|November 14, 2009
Antimetastatic role of Smad4 signaling in colorectal cancerBixiang Zhang, Sunil K Halder, Nilesh D Kashikar, et al.
Pageof 23